UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiac Sarcoidosis

Journal of the American College of Cardiology, 2016-07, Vol.68 (4), p.411-421

2016

Volltextzugriff (PDF)

Cardiac manifestations of sarcoidosis: diagnosis and management

European heart journal, 2017-09, Vol.38 (35), p.2663-2670

2017

Volltextzugriff (PDF)

Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic Review

Canadian journal of cardiology, 2013-09, Vol.29 (9), p.1034-1041

2013

Volltextzugriff (PDF)

Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle-Aged Adults

Journal of cardiovascular electrophysiology, 2014-08, Vol.25 (8), p.875-881

2014

Volltextzugriff (PDF)

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review

Journal of the American Heart Association, 2021-09, Vol.10 (17), p.e021183

2021

Volltextzugriff (PDF)

Efficacy and safety of driver‐guided catheter ablation for atrial fibrillation: A systematic review and meta‐analysis

Journal of cardiovascular electrophysiology, 2017-12, Vol.28 (12), p.1371-1378

2017

Volltextzugriff (PDF)

Swallowing-induced atrial tachycardia

Canadian Medical Association journal (CMAJ), 2018-04, Vol.190 (16), p.E507-E509

2018

Volltextzugriff (PDF)

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial

Journal of cardiovascular electrophysiology, 2018-04, Vol.29 (4), p.603-608

2018

Volltextzugriff (PDF)

Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping

Canadian journal of cardiology, 2020-12, Vol.36 (12), p.1956-1964

2020

Volltextzugriff (PDF)

Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study

American heart journal plus, 2022-12, Vol.24, p.None-None, Article 100224

2022

Volltextzugriff (PDF)

Atrioesophageal Fistula in the Era of Atrial Fibrillation Ablation: A Review

Canadian journal of cardiology, 2014-04, Vol.30 (4), p.388-395

2014

Volltextzugriff (PDF)

Three‐year outcomes and reconnection patterns after initial contact force guided pulmonary vein isolation for paroxysmal atrial fibrillation

Journal of cardiovascular electrophysiology, 2017-09, Vol.28 (9), p.984-993

2017

Volltextzugriff (PDF)

Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e017086-e017086

2020

Volltextzugriff (PDF)

Isolated Cardiac Sarcoidosis: Establishing the Diagnosis With Electroanatomic Mapping-Guided Endomyocardial Biopsy

Canadian journal of cardiology, 2013-08, Vol.29 (8), p.1015.e1-1015.e3

2013

Volltextzugriff (PDF)

How to risk-stratify cardiac sarcoidosis patients with normal or near-normal ventricular function?

Heart rhythm, 2022-03, Vol.19 (3), p.361-362

2022

Volltextzugriff (PDF)

Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, Canada

Journal of the American Heart Association, 2021-01, Vol.10 (1), p.e016071-e016071

2021

Volltextzugriff (PDF)

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

The New England journal of medicine, 2016-07, Vol.375 (2), p.111-121

2016

Volltextzugriff (PDF)

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)

European heart journal, 2018-11, Vol.39 (44), p.3973-3979

2018

Volltextzugriff (PDF)

Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT)

Heliyon, 2023-12, Vol.9 (12), p.e22229-e22229, Article e22229

2023

Volltextzugriff (PDF)

Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review

Heart rhythm, 2011-07, Vol.8 (7), p.1083-1087

2011

Volltextzugriff (PDF)

Prognostic Information From Endocardial Voltage Mapping at the Time of Endomyocardial Biopsy for the Diagnosis of Cardiac Amyloidosis

Canadian journal of cardiology, 2024-03, Vol.40 (3), p.385-387

2024

Volltextzugriff (PDF)

COUNTERPOINT: Should Isolated Cardiac Sarcoidosis Be Considered a Significant Manifestation of Sarcoidosis? No

Chest, 2021-07, Vol.160 (1), p.38-42

2021

Volltextzugriff (PDF)

Prognostic value of low-voltage area burden in atrial fibrillation

Heart rhythm, 2024-04, Vol.21 (4), p.387-388

2024

Volltextzugriff (PDF)

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines

Canadian journal of cardiology, 2017-08, Vol.33 (8), p.977-990

2017

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(164)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac Sarcoidosis

Cardiac manifestations of sarcoidosis: diagnosis and management

Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic Review

Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle-Aged Adults

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review

Efficacy and safety of driver‐guided catheter ablation for atrial fibrillation: A systematic review and meta‐analysis

Swallowing-induced atrial tachycardia

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial

Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping

Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study

Atrioesophageal Fistula in the Era of Atrial Fibrillation Ablation: A Review

Three‐year outcomes and reconnection patterns after initial contact force guided pulmonary vein isolation for paroxysmal atrial fibrillation

Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes

Isolated Cardiac Sarcoidosis: Establishing the Diagnosis With Electroanatomic Mapping-Guided Endomyocardial Biopsy

How to risk-stratify cardiac sarcoidosis patients with normal or near-normal ventricular function?

Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, Canada

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)

Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT)

Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review

Prognostic Information From Endocardial Voltage Mapping at the Time of Endomyocardial Biopsy for the Diagnosis of Cardiac Amyloidosis

COUNTERPOINT: Should Isolated Cardiac Sarcoidosis Be Considered a Significant Manifestation of Sarcoidosis? No

Prognostic value of low-voltage area burden in atrial fibrillation

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines

Failure rate of the Riata lead under advisory: A report from the CHRS Device Committee

Suchergebnisse filtern